Literature DB >> 33709037

COVID-19 - exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study.

Peter Hanlon1, Fergus Chadwick1, Anoop Shah2, Rachael Wood2, Jon Minton3, Gerry McCartney4, Colin Fischbacher3, Frances S Mair1, Dirk Husmeier1, Jason Matthiopoulos1, David A McAllister1,3.   

Abstract

Background: COVID-19 is responsible for increasing deaths globally. As most people dying with COVID-19 are older with underlying long-term conditions (LTCs), some speculate that YLL are low. We aim to estimate YLL attributable to COVID-19, before and after adjustment for number/type of LTCs, using the limited data available early in the pandemic.
Methods:  We first estimated YLL from COVID-19 using WHO life tables, based on published age/sex data from COVID-19 deaths in Italy. We then used aggregate data on number/type of LTCs in a Bayesian model to estimate likely combinations of LTCs among people dying with COVID-19. We used routine UK healthcare data from Scotland and Wales to estimate life expectancy based on age/sex/these combinations of LTCs using Gompertz models from which we then estimate YLL.
Results:  Using the standard WHO life tables, YLL per COVID-19 death was 14 for men and 12 for women. After adjustment for number and type of LTCs, the mean YLL was slightly lower, but remained high (11.6 and 9.4 years for men and women, respectively). The number and type of LTCs led to wide variability in the estimated YLL at a given age (e.g. at ≥80 years, YLL was >10 years for people with 0 LTCs, and <3 years for people with ≥6). Conclusions: Deaths from COVID-19 represent a substantial burden in terms of per-person YLL, more than a decade, even after adjusting for the typical number and type of LTCs found in people dying of COVID-19. The extent of multimorbidity heavily influences the estimated YLL at a given age. More comprehensive and standardised collection of data (including LTC type, severity, and potential confounders such as socioeconomic-deprivation and care-home status) is needed to optimise YLL estimates for specific populations, and to understand the global burden of COVID-19, and guide policy-making and interventions. Copyright:
© 2021 Hanlon P et al.

Entities:  

Keywords:  COVID-19; Coronavirus; Epidemiology; Multimorbidity; noncommunicable diseases

Year:  2021        PMID: 33709037      PMCID: PMC7927210.3          DOI: 10.12688/wellcomeopenres.15849.3

Source DB:  PubMed          Journal:  Wellcome Open Res        ISSN: 2398-502X


  20 in total

1.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

2.  Development and validation of the Cambridge Multimorbidity Score.

Authors:  Rupert A Payne; Silvia C Mendonca; Marc N Elliott; Catherine L Saunders; Duncan A Edwards; Martin Marshall; Martin Roland
Journal:  CMAJ       Date:  2020-02-03       Impact factor: 8.262

3.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321

4.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

5.  COVID-19 - exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study.

Authors:  Peter Hanlon; Fergus Chadwick; Anoop Shah; Rachael Wood; Jon Minton; Gerry McCartney; Colin Fischbacher; Frances S Mair; Dirk Husmeier; Jason Matthiopoulos; David A McAllister
Journal:  Wellcome Open Res       Date:  2021-03-01

6.  Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.

Authors:  Bhautesh Dinesh Jani; Peter Hanlon; Barbara I Nicholl; Ross McQueenie; Katie I Gallacher; Duncan Lee; Frances S Mair
Journal:  BMC Med       Date:  2019-04-10       Impact factor: 8.775

7.  Reflection on modern methods: years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality.

Authors:  Ramon Martinez; Patricia Soliz; Roberta Caixeta; Pedro Ordunez
Journal:  Int J Epidemiol       Date:  2019-08-01       Impact factor: 7.196

8.  Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study.

Authors:  Marcello Morciano; Jonathan Stokes; Evangelos Kontopantelis; Ian Hall; Alex J Turner
Journal:  BMC Med       Date:  2021-03-05       Impact factor: 8.775

9.  Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study.

Authors:  Robert M Shavelle; David R Paculdo; Scott J Kush; David M Mannino; David J Strauss
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  28 in total

1.  Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.

Authors:  Lin Liu; Shu-Yu Ni; Wei Yan; Qing-Dong Lu; Yi-Miao Zhao; Ying-Ying Xu; Huan Mei; Le Shi; Kai Yuan; Ying Han; Jia-Hui Deng; Yan-Kun Sun; Shi-Qiu Meng; Zheng-Dong Jiang; Na Zeng; Jian-Yu Que; Yong-Bo Zheng; Bei-Ni Yang; Yi-Miao Gong; Arun V Ravindran; Thomas Kosten; Yun Kwok Wing; Xiang-Dong Tang; Jun-Liang Yuan; Ping Wu; Jie Shi; Yan-Ping Bao; Lin Lu
Journal:  EClinicalMedicine       Date:  2021-09-08

2.  The Effect of the COVID-19 Pandemic on the Elderly: Population Fatality Rates, COVID Mortality Percentage, and Life Expectancy Loss.

Authors:  Paula Natalia Barreto Parra; Vladimir Atanasov; Jeff Whittle; John Meurer; Qian Eric Luo; Ruohao Zhang; Bernard Black
Journal:  Elder Law J       Date:  2022-02-17

3.  The COVID-19 Disease Burden in Germany in 2020—Years of Life Lost to Death and Disease Over the Course of the Pandemic.

Authors:  Alexander Rommel; Elena von der Lippe; Dietrich Plass; Thomas Ziese; Michaela Diercke; Matthias An der Heiden; Sebastian Haller; Annelene Wengler
Journal:  Dtsch Arztebl Int       Date:  2021-03-05       Impact factor: 5.594

4.  COVID-19 - exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study.

Authors:  Peter Hanlon; Fergus Chadwick; Anoop Shah; Rachael Wood; Jon Minton; Gerry McCartney; Colin Fischbacher; Frances S Mair; Dirk Husmeier; Jason Matthiopoulos; David A McAllister
Journal:  Wellcome Open Res       Date:  2021-03-01

5.  Closed for business: The mortality impact of business closures during the Covid-19 pandemic.

Authors:  Dion Bongaerts; Francesco Mazzola; Wolf Wagner
Journal:  PLoS One       Date:  2021-05-14       Impact factor: 3.240

Review 6.  Ethics of vaccination: Should capability measures be used to inform SARS-CoV-2 vaccination strategies?

Authors:  Michael R Millar; Yannis Gourtsoyannis; Angelina Jayakumar
Journal:  Br J Clin Pharmacol       Date:  2021-05-07       Impact factor: 3.716

7.  Inferring UK COVID-19 fatal infection trajectories from daily mortality data: Were infections already in decline before the UK lockdowns?

Authors:  Simon N Wood
Journal:  Biometrics       Date:  2021-04-07       Impact factor: 1.701

8.  Different approaches to quantify years of life lost from COVID-19.

Authors:  Tamás Ferenci
Journal:  Eur J Epidemiol       Date:  2021-06-10       Impact factor: 8.082

9.  The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany.

Authors:  Afschin Gandjour
Journal:  Q Rev Econ Finance       Date:  2020-10-14

10.  Global perspective of COVID-19 epidemiology for a full-cycle pandemic.

Authors:  John P A Ioannidis
Journal:  Eur J Clin Invest       Date:  2020-10-25       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.